Sorting by

×

Harvard’s discrimination problem runs deep. Are they willing to fix it?

With the Trump administration threatening to cut off its federal support, Harvard recently released its long-awaited internal report detailing rampant national-origin discrimination on campus – especially against Israelis and Jews. The administration claims that Harvard is rotten to the bone, hollowed out by ideological one-sidedness and an emphasis on social-justice activism rather than genuine inquiry….

Read More

HHS SEC ROBERT F KENNEDY JR: American patients pay more so others can pay less — that stops now

President Donald Trump’s bold executive order on drug pricing isn’t just policy—it’s a revolution in healthcare affordability. The plan is simple yet transformative: ensure Americans pay no more for medications than citizens of other wealthy nations. Consider this stark reality: a GLP-1 drug costing $88 in London commands $1,000 in the United States. Even after…

Read More

Weight loss, diabetes drugs can cause mood changes: What to know about behavioral side effects

GLP-1 receptor agonists (GLP-1 RAs), medications that help control type 2 diabetes and obesity, can have a profound impact on physical wellness – but what about mental health? Some examples of these medications include semaglutides, such as Ozempic and Wegovy, and liraglutide, like Victoza and Saxenda. Various studies have pointed toward GLP-1 RAs causing mental…

Read More